{"disease":{"id":"immune-related-adverse-event","name":"immune related adverse event"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05934214","title":"EXploring Immune-related Adverse Events of Immune checkpoinT Inhibitors Using VigiBase, the WHO Pharmacovigilance Database","phase":"","overall_status":"COMPLETED","enrollment_count":141630,"lead_sponsor_name":"Groupe Hospitalier Pitie-Salpetriere","has_results":false},{"nct_id":"NCT04115410","title":"PD-1 Immune Checkpoint Inhibitors and Immune-Related Adverse Events: a Cohort Study","phase":"","overall_status":"UNKNOWN","enrollment_count":4724,"lead_sponsor_name":"Sungkyunkwan University","has_results":false},{"nct_id":"NCT06702566","title":"The Effect of Serum Ferritin in irAE","phase":"NA","overall_status":"RECRUITING","enrollment_count":1500,"lead_sponsor_name":"Tianjin Medical University Cancer Institute and Hospital","has_results":false},{"nct_id":"NCT07357636","title":"Longitudinal Cohort Study of Immune-Related Adverse Events in Solid Tumor Patients Treated With Immune Checkpoint Inhibitors","phase":"","overall_status":"RECRUITING","enrollment_count":940,"lead_sponsor_name":"Shantou University Medical College","has_results":false},{"nct_id":"NCT07453342","title":"Immune-Related Adverse Events After Cancer Immunotherapy and Safety of Treatment Rechallenge","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false},{"nct_id":"NCT03948724","title":"Impact of Therapeutic Patient Education on the Toxicity of Immune Checkpoint Inhibitors in Oncology","phase":"NA","overall_status":"COMPLETED","enrollment_count":411,"lead_sponsor_name":"Institut Cancerologie de l'Ouest","has_results":false},{"nct_id":"NCT05799898","title":"Fast-Track Cardiovascular Assessment for Suspicion of Cardiovascular Events on Immunecheckpoint Inhibitors","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Institut Mutualiste Montsouris","has_results":false},{"nct_id":"NCT06440811","title":"Efficacy and Safety of Neoadjuvant Nivolumab Plus SOX Versus Nivolumab Plus FLOT in Patients With HER2-negative Gastric and Gastroesophageal Junction Adenocarcinoma","phase":"","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"Xijing Hospital","has_results":false},{"nct_id":"NCT05699915","title":"Extensive CArdioVAscular Characterization and Follow-up of Patients Receiving Immune Checkpoint Inhibitors","phase":"NA","overall_status":"TERMINATED","enrollment_count":105,"lead_sponsor_name":"Algemeen Ziekenhuis Maria Middelares","has_results":false},{"nct_id":"NCT06789601","title":"Evaluating Informatics-assisted Immune-related Adverse Event Detection to Improve Registration Onto a Biorepository","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":false},{"nct_id":"NCT04840355","title":"Multi-Centre, Prospective, Non-Interventional Study to Intensively Monitor the Safety of Sintilimab in Clinical Practice Among Chinese Patients","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Guohui Li","has_results":false},{"nct_id":"NCT06613165","title":"Exploring the Treatment Duration of PD-1 Neoadjuvant Therapy in Stage II-III dMMR Rectal Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Xijing Hospital","has_results":false},{"nct_id":"NCT06860542","title":"Inhaled Budesonide for REcurrence Prevention and Adjuvant THerapy in Checkpoint Inhibitor Pneumonitis","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":94,"lead_sponsor_name":"AHS Cancer Control Alberta","has_results":false},{"nct_id":"NCT05544292","title":"Rheumatic IMmune-Related Adverse Events in Patients Treated With Immune Check Point Inhibitors","phase":"","overall_status":"COMPLETED","enrollment_count":69,"lead_sponsor_name":"Diakonhjemmet Hospital","has_results":false},{"nct_id":"NCT07167251","title":"Management of Immune Checkpoint Inhibition-related Hepatitis Using Low-dose Corticosteroids","phase":"","overall_status":"RECRUITING","enrollment_count":63,"lead_sponsor_name":"University Hospital, Basel, Switzerland","has_results":false},{"nct_id":"NCT05832606","title":"Food Intervention to Reduce Immunotherapy ToXicity","phase":"NA","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Universitair Ziekenhuis Brussel","has_results":false},{"nct_id":"NCT04807127","title":"A Single-cell Approach to Identify Biomarkers of Pulmonary Toxicity for Immune Checkpoint Blockade","phase":"","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Universitaire Ziekenhuizen KU Leuven","has_results":false},{"nct_id":"NCT05700565","title":"Treatment of Immune-related Adverse Events Refractory to Standard Therapy and Associated Changes in Immunophenotype","phase":"","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Lucie Heinzerling","has_results":false},{"nct_id":"NCT04305145","title":"Infliximab for Treatment of Immune Checkpoint Inhibitor Colitis","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":42,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT06089967","title":"Immune-Related Adverse Events and Associated Biomarkers in Patients Receiving Cancer Immunotherapy","phase":"","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Duke University","has_results":false},{"nct_id":"NCT06243250","title":"Hyperpolarized 13C-MRI and Metabolomics for Immune-related Adverse Events","phase":"","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Chang Gung Memorial Hospital","has_results":false},{"nct_id":"NCT07430579","title":"Adebrelimab Combined With Chemotherapy for the Esophageal Squamous Cell Carcinoma","phase":"NA","overall_status":"RECRUITING","enrollment_count":25,"lead_sponsor_name":"The Second Hospital of Shandong University","has_results":false},{"nct_id":"NCT05414552","title":"ECP for Immune-related Adverse Events After Checkpoint Inhibitor Treatment","phase":"","overall_status":"COMPLETED","enrollment_count":11,"lead_sponsor_name":"University of Freiburg","has_results":false},{"nct_id":"NCT06278857","title":"SATELLITE Study (feaSibility sAfeTy Efficacy dostarLimab earLy-stage defIcient endomeTrial cancEr)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":10,"lead_sponsor_name":"Queensland Centre for Gynaecological Cancer","has_results":false}],"total":24},"guidelines":[],"source":"Drug Landscape verified database"}